Skip to main content
OpenTrials

Clinical trial condition

Neutropenia

Explore clinical trials studying Neutropenia. Study availability and eligibility vary by location and protocol.

133 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Neutropenia trial results

Completed

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

NCT01724866

Conditions
Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations
  • Arizona Center for Cancer Care Glendale, Arizona, United States
  • Desert Springs Cancer Care Scottsdale, Arizona, United States
  • California Cancer Associates for Research and Excellence Fresno, California, United States
  • Beaver Medical Group Highland, California, United States
View all 27 locations
View Trial Details
Completed

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

NCT04710212

Conditions
Agranulocytosis, Bloodstream Infection, Cytopenia, +18 more
Locations
  • University of California San Fransisco Medical Center San Francisco, California, United States
  • Hackensack Meridian Health Nutley, New Jersey, United States
  • Mount Sinai Hospital New York, United States
  • University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)

NCT02643420

Conditions
Agranulocytosis, Breast Cancer, Breast Diseases, +11 more
Locations
  • Arizona Center for Cancer Care Glendale, Arizona, United States
  • Arizona Clinical Research Center/ ACRC Tucson, Arizona, United States
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
View all 81 locations
View Trial Details
Completed

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

NCT02953340

Conditions
Agranulocytosis, Breast Cancer, Breast Diseases, +11 more
Locations
  • ACRC/ Arizona Clinical Research Center Inc. Tucson, Arizona, United States
  • Yuma Regional Cancer Center Yuma, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • NEA Baptist Clinic | Fowler Family Center for Cancer Care Jonesboro, Arkansas, United States
View all 74 locations
View Trial Details
Completed

A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

NCT02190721

Conditions
Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations
  • Teva Investigational Site 12958 Long Beach, California, United States
  • Teva Investigational Site 12951 Los Angeles, California, United States
  • Teva Investigational Site 12954 Jackson, Mississippi, United States
  • Teva Investigational Site 12953 Las Vegas, Nevada, United States
View all 33 locations
View Trial Details
Completed

Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

NCT01307579

Conditions
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +42 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 179 locations
View Trial Details

Related conditions